Class / Patent application number | Description | Number of patent applications / Date published |
435457000 | Helper virus is present | 6 |
20090004743 | HELPER VIRUS-FREE AAV PRODUCTION - A method for the production of adeno-associated virus stocks and recombinant adeno-associated virus stocks that are substantially free of contaminating helper virus is described. The method utilizes transfection with helper virus vectors to replace the infection with helper virus used in the conventional method. | 01-01-2009 |
20090275138 | PRODUCTION OF rAAV IN VERO CELLS USING PARTICULAR ADENOVIRUS HELPERS - The present invention relates to methods and materials for recombinant adeno-associated virus production. More particularly, in some embodiments the invention contemplates the use of an adenovirus known as Simian Adenovirus 13 (SAdV-13) and Vero cells for production of recombinant adeno-associated virus (rAAV). | 11-05-2009 |
20090291503 | Recombinant Adeno-Associated Virus Production - The present invention relates to methods and materials for recombinant adeno-associated virus production. More particularly, the invention relates to use of recombinant adenovirus encoding adeno-associated virus protein in recombinant adeno-associated virus production methods. | 11-26-2009 |
20100227407 | AAV4 VECTOR AND USES THEREOF - The present invention provides an adeno-associated virus 4 (AAV4) virus and vectors and particles derived therefrom. In addition, the present invention provides methods of delivering a nucleic acid to a cell using the AAV4 vectors and particles. | 09-09-2010 |
20110229971 | RECOMBINANT VIRUS PRODUCTION USING MAMMALIAN CELLS IN SUSPENSION - The invention generally provides methods for producing recombinant AAV viral particles using cells grown in suspension. The invention provides recombinant AAV particles for use in methods for delivering genes encoding therapeutic proteins, and methods for using the recombinant AAV particles in gene therapy. | 09-22-2011 |
20130244331 | RECOMBINANT VIRUS PRODUCTION USING MAMMALIAN CELLS IN SUSPENSION - The invention generally provides methods for producing recombinant AAV viral particles using cells grown in suspension. The invention provides recombinant AAV particles for use in methods for delivering genes encoding therapeutic proteins, and methods for using the recombinant AAV particles in gene therapy. | 09-19-2013 |